CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,818,000 | -20.2% | 948,389 | -36.2% | 26.68% | +185.5% |
| Q2 2021 | $17,323,000 | -44.3% | 1,486,986 | -41.7% | 9.34% | -18.4% |
| Q1 2021 | $31,098,000 | +29.8% | 2,549,031 | +33.1% | 11.45% | +100.8% |
| Q4 2020 | $23,959,000 | +10.7% | 1,915,219 | +33.2% | 5.70% | -48.0% |
| Q3 2020 | $21,634,000 | +33.7% | 1,437,445 | +117.8% | 10.97% | +4.7% |
| Q2 2020 | $16,176,000 | +39.0% | 659,987 | -19.5% | 10.48% | -16.6% |
| Q1 2020 | $11,636,000 | +157.2% | 820,000 | +187.7% | 12.56% | +416.9% |
| Q4 2019 | $4,524,000 | – | 285,000 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |